Covington Capital Management Abbott Laboratories Transaction History

Covington Capital Management

$23.2 Billion
Q3 2022

A detailed history of Covington Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Covington Capital Management holds 255,162 shares of ABT stock, worth $28.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

255,162

Previous 254,446 0.28%

Holding current value

$28.7 Million

Previous $27.6 Million 10.7%

% of portfolio

0.11%

Previous 1.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $69,280 - $80,213	716 Added 0.28%	255,162 $24.7 Million
Q2 2022 Jul 08, 2022	BUY	$102.07 - $123.37 $68,386 - $82,657	670 Added 0.26%	254,446 $27.6 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1.02 Million - $1.25 Million	8,957 Added 3.66%	253,776 $30 Million
Q4 2021 Feb 16, 2022	BUY	$115.53 - $141.46 $132,975 - $162,820	1,151 Added 0.47%	244,819 $34.5 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $424,642 - $469,778	3,640 Added 1.52%	243,668 $28.8 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $571,900 - $673,209	5,406 Added 2.3%	240,028 $27.8 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $136,703 - $161,056	1,256 Added 0.54%	234,622 $28.1 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $206,850 - $225,407	1,970 Added 0.85%	233,366 $25.6 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $445,095 - $540,535	4,857 Added 2.14%	231,396 $25.2 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $462,329 - $591,724	6,038 Added 2.74%	226,539 $20.7 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $338,285 - $494,666	5,385 Added 2.5%	220,501 $17.4 Million
Q4 2019 Feb 18, 2020	SELL	$78.51 - $87.4 $538,264 - $599,214	-6,856 Reduced 3.09%	215,116 $18.7 Million
Q3 2019 Nov 18, 2019	BUY	$81.84 - $88.74 $304,362 - $330,024	3,719 Added 1.7%	221,972 $18.6 Million
Q2 2019 Aug 15, 2019	BUY	$72.88 - $85.0 $18,803 - $21,930	258 Added 0.12%	218,253 $18.4 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $583,663 - $705,648	8,814 Added 4.21%	217,995 $17.4 Million
Q4 2018 Feb 15, 2019	BUY	$65.56 - $74.27 $949,177 - $1.08 Million	14,478 Added 7.44%	209,181 $15.1 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $1.26 Million - $1.53 Million	20,795 Added 11.96%	194,703 $14.3 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $608,802 - $671,935	-10,575 Reduced 5.73%	173,908 $10.6 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $97,065 - $109,744	-1,725 Reduced 0.93%	184,483 $11.1 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $199,958 - $214,075	-3,725 Reduced 1.96%	186,208 $10.6 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $212,665 - $237,357	-4,425 Reduced 2.28%	189,933 $10.1 Million
Q2 2017 Aug 16, 2017	BUY	N/A	194,358	194,358 $9.45 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.

Account

Covington Capital Management Abbott Laboratories Transaction History